Skip to main content
Premium Trial:

Request an Annual Quote

Pangea Systems Unveils Bioinformatics Dataset

Premium

OAKLAND, Calif.--Privately held computer developer Pangea Systems announced the release of the first commercially available bioinformatics metabolic pathways dataset for E. coli last week. EcoCyc 4.0 allows researchers to access an integrated metabolic pathways dataset and software environment that links the complete metabolic network and the entire genome of a biomedically important model organism. A graphical user interface enables biologically intuitive exploration of cellular metabolism, the company said. This can be done by visualizing individual pathways or the entire metabolic map.

Pangea said EcoCyc represents its latest commitment to accelerating and simplifying the drug discovery process by providing integrated database management, analysis algorithms, and visualization tools for biological and chemical information.

EcoCyc 4.0 is available through the Web and links approximately 2,000 more genes than the previously available version. Additionally, EcoCyc 4.0 goes beyond earlier E. coli metabolic pathway descriptions by adding two-component signal transduction proteins, the company said. EcoCyc is available at www.ecocycpangeasystems.com.

Filed under

The Scan

Researchers Compare WGS, Exome Sequencing-Based Mendelian Disease Diagnosis

Investigators find a diagnostic edge for whole-genome sequencing, while highlighting the cost advantages and improving diagnostic rate of exome sequencing in EJHG.

Researchers Retrace Key Mutations in Reassorted H1N1 Swine Flu Virus With Avian-Like Features

Mutations in the acidic polymerase-coding gene boost the pathogenicity and transmissibility of Eurasian avian-like H1N1 swine influenza viruses, a PNAS paper finds.

Genome Sequences Reveal Evolutionary History of South America's Canids

An analysis in PNAS of South American canid species' genomes offers a look at their evolutionary history, as well as their relationships and adaptations.

Lung Cancer Response to Checkpoint Inhibitors Reflected in Circulating Tumor DNA

In non-small cell lung cancer patients, researchers find in JCO Precision Oncology that survival benefits after immune checkpoint blockade coincide with a dip in ctDNA levels.